Lv1
44 积分 2024-02-03 加入
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
1个月前
已完结
Optimal Margin for Sublobar Resection of Invasive Lung Adenocarcinoma Presenting as Mixed Ground-Glass Nodules
1个月前
已完结
Segmentectomy versus lobectomy in non-small-cell lung cancer with pathologically invasive features: a post-hoc supplementary analysis of a multicenter, Phase 3 trial JCOG0802/WJOG4607L
1个月前
已完结
Palpation-Free Robot-Assisted Thoracoscopic Wedge Resection Using Radiofrequency Identification Marking for Synchronous Multiple Primary Lung Cancers
1个月前
已完结
Robotic-assisted bronchoscopy for histopathologic subtyping of primary lung adenocarcinoma
4个月前
已完结
miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
4个月前
已完结
SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
5个月前
已完结
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
5个月前
已完结
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
5个月前
已完结
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
7个月前
已完结
皖公网安备34019202002308
